Daniel S. Lorrain

CTNM

Daniel S. Lorrain serves as officer: Chief Scientific Officer at Contineum Therapeutics, Inc. (CTNM). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

0 trades

$0.00

Total Sells

16 trades

$1.34M

Net Position

Net Seller

$1.34M

Companies Traded

CTNM

Active Period

Nov 2024 – Jul 2026

16 total trades

Most Recent

Sell CTNM

Jul 10, 2026 · $400.00

Daniel S. Lorrain's Insider Trading at Contineum Therapeutics, Inc. (CTNM)

Buys

0 · $0.00

Sells

16 · $1.34M

Total Shares Bought

Total Shares Sold

90,558

CTNM Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Jul 10, 2026	Sell	25	$16.00	$400.00	135,202
Jul 2, 2026	Sell	37,179	$15.99	$594.6K	139,372
Jun 1, 2026	Sell	4,170	$13.16	$54.9K	139,372
May 1, 2026	Sell	4,170	$13.12	$54.7K	143,842
Apr 6, 2026	Sell	4,170	$13.43	$56.0K	147,712
Mar 2, 2026	Sell	4,170	$15.01	$62.6K	151,882
Feb 26, 2026	Sell	8,124	$16.02	$130.2K	156,052
Feb 19, 2026	Sell	100	$16.00	$1.6K	0
Feb 13, 2026	Sell	400	$16.00	$6.4K	156,052
Feb 5, 2026	Sell	4,170	$14.94	$62.3K	157,222
Feb 3, 2026	Sell	4,170	$14.94	$62.3K	0
Jan 6, 2026	Sell	4,170	$10.44	$43.5K	160,722
Jan 5, 2026	Sell	4,170	$10.44	$43.5K	0
Dec 23, 2025	Sell	4,170	$12.23	$51.0K	0
Nov 25, 2024	Sell	1,010	$16.02	$16.2K	0
Nov 18, 2024	Sell	6,190	$16.38	$101.4K	0

Related Insiders

Carmine N. Stengone

director, officer: CEO and President

CTNMSell · Jul 8, 2026

Tim Watkins

officer: CMO & Head of Development

CTNMSell · Jul 1, 2026

Explore More Insider Trading Data

CTNM Insider Trading Activity

View all insider trades at Contineum Therapeutics, Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity